Literature DB >> 9639524

Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.

U Döbbeling1, R Dummer, E Laine, N Potoczna, J Z Qin, G Burg.   

Abstract

In this study we investigated the role of interleukin-15 (IL-15) in the immunobiology of cutaneous T-cell lymphoma (CTCL) cells. Using cell culture techniques, reverse transcriptase-polymerase chain reaction (RT-PCR), and immunhistochemistry we found that IL-15, like IL-7, is a growth factor for the Sézary cell line SeAx and that both cytokines prolonged the survival of malignant T cells directly isolated from Sézary syndrome (SS) patients. Both IL-15 and IL-7 were more potent than IL-2. IL-4 and IL-9, whose receptors share the same gamma chain with the receptors of IL-2, IL-7, and IL-15, did not sustain the growth of CTCL cells, indicating that signaling through the common gamma chain (gammac) is not sufficient for continuous growth. IL-13 and tumor necrosis factor-alpha (TNF-alpha) had no effect. IL-7 and IL-15 also supported the growth of SeAx cells in the presence of the apoptosis inducing agents dexamethasone and retinoic acid. The analysis of patient Sézary cells and three CTCL cell lines by RT-PCR showed that all these cells expressed IL-15 mRNA, but only a few (25%) produced IL-7 mRNA. Immunohistological analyses of skin biopsy samples of SS and Mycosis fungoides patients showed immunoreactivity for IL-15 in basal cell layer keratinocytes and in the infiltrating lymphocytes. We conclude that IL-15 is a growth or viability factor for CTCL-derived cell lines or shortly cultivated Sézary cells. The findings that IL-15 mRNA can be detected in Sézary syndrome peripheral blood mononuclear cells and that the IL-15 protein is detected in skin sections from CTCL patients suggest that IL-15 plays an important role in the biology of CTCL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639524

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

Review 1.  The functions of cytokines and their uses in toxicology.

Authors:  J R Foster
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

2.  Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma.

Authors:  Kei-ichi Yamanaka; Rachael Clark; Benjamin Rich; Rebecca Dowgiert; Kazuki Hirahara; Daniel Hurwitz; Michio Shibata; Nina Mirchandani; David A Jones; Deborah S Goddard; Sara Eapen; Hitoshi Mizutani; Thomas S Kupper
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

3.  Interleukin-16 as a marker of Sézary syndrome onset and stage.

Authors:  Jillian Richmond; Marina Tuzova; Ashley Parks; Natalie Adams; Elizabeth Martin; Marianne Tawa; Lynne Morrison; Keri Chaney; Thomas S Kupper; Clara Curiel-Lewandrowski; William Cruikshank
Journal:  J Clin Immunol       Date:  2010-09-28       Impact factor: 8.317

4.  IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.

Authors:  Michal Marzec; Xiaobin Liu; Monika Kasprzycka; Agnieszka Witkiewicz; Puthiyaveettil N Raghunath; Mouna El-Salem; Erle Robertson; Niels Odum; Mariusz A Wasik
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

Review 5.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

6.  The IL-15 cytokine system provides growth and survival signals in Hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells.

Authors:  K Ullrich; F Blumenthal-Barby; B Lamprecht; K Köchert; D Lenze; M Hummel; S Mathas; B Dörken; M Janz
Journal:  Leukemia       Date:  2014-12-09       Impact factor: 11.528

Review 7.  Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.

Authors:  Thomas A Waldmann; Jing Chen
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

8.  Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome.

Authors:  Laura Y McGirt; Christopher Thoburn; Allan Hess; Eric C Vonderheid
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-08       Impact factor: 3.135

9.  MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.

Authors:  Erica Ballabio; Tracey Mitchell; Marloes S van Kester; Stephen Taylor; Heather M Dunlop; Jianxiang Chi; Isabella Tosi; Maarten H Vermeer; Daniela Tramonti; Nigel J Saunders; Jacqueline Boultwood; James S Wainscoat; Francesco Pezzella; Sean J Whittaker; Cornelius P Tensen; Christian S R Hatton; Charles H Lawrie
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

Review 10.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.